Controversias en Tromboembolismo Pulmonar Masivo

Autores/as

  • Marcelo Mercado Departamento de Medicina IntensivaFacultad de Medicina, Pontificia Universidad Católica de Chile
  • Andrés Aizman Departamento de Medicina InternaFacultad de Medicina, Pontificia Universidad Católica de Chile
  • Max Andresen Departamento de Medicina IntensivaFacultad de Medicina, Pontificia Universidad Católica de Chile

Palabras clave:

Pulmonary embolism, Thrombectomy, Thrombolytic therapy

Resumen

CONTROVERSIES IN MASSIVE PULMONARY EMBOLISM

Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria  for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular  obstruction and the previous cardiopulmonary status .Right ventricular dysfunction  is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological  invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.

Biografía del autor/a

Max Andresen, Departamento de Medicina IntensivaFacultad de Medicina, Pontificia Universidad Católica de Chile

Unidad de Paciente Crítico Hospital Clínico universidad Católica Marcoleta 367, 4º piso, Santiago, Chile Teléfono: 02-3543265 Fax: 02-3543703 Mail: andresen@med.puc.cl

Descargas

Publicado

2013-04-05

Cómo citar

Mercado, M., Aizman, A., & Andresen, M. (2013). Controversias en Tromboembolismo Pulmonar Masivo. Revista Médica De Chile, 141(4). Recuperado a partir de https://mail.revistamedicadechile.cl/index.php/rmedica/article/view/2077

Número

Sección

Artículos de revisión

Artículos más leídos del mismo autor/a

1 2 3 4 > >>